English
In the fields of modern biopharmaceuticals, vaccine production, and cell and gene therapy, the concept of the cell factory analogy is emerging as a key technology driving production innovation. Its advanced multi-layered design and precise piping system not only significantly enhance production efficiency but also effectively reduce the risk of contamination, injecting new vitality into the industry.
Space Optimization for Increased Production Efficiency
One of the standout features of the cell factory analogy is its multi-layered structure design. By cleverly utilizing space, this design allows for more cultivation operations to be conducted within a limited area, thereby dramatically boosting production efficiency. This space-optimized solution is particularly suitable for biopharmaceutical companies and vaccine production lines that require large-scale cell cultivation. It makes the production process more compact and organized, ensuring both operational efficiency and flexibility.
Closed System Transfers to Minimize Contamination Risks
The specialized piping system in the cell factory analogy enables closed system transfers of liquids, an innovative design that effectively prevents external contamination. Maintaining a sterile environment during cell cultivation is crucial. By employing this closed system, the cell factory analogy provides a controlled production environment, greatly reducing potential contamination risks and ensuring the safety and quality of the products.
In conclusion, the cell factory analogy excels in areas such as vaccine production and cell and gene therapy. Its efficient design not only meets the demands of large-scale production but also handles the complex challenges of personalized therapies. This reliable solution supports high-demand production tasks, making the process more stable and secure.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.